The development of a monoclonal antibody for Group B rotaviruses enables sensitive immunoassays for viral characterization and epidemiological studies.
Answers are grounded in this paper and cite their sources.
May aid GBR immunoassay development for research; leaves open human clinical validation from this animal study.
Group B rotaviruses (GBRs) are fastidious agents which cause enteric disease in humans and a number of other animal species. Detailed study of the role of GBRs in human disease has been hampered by the lack of immunoreagents suitable for large-scale studies. We developed a monoclonal antibody which recognizes a group-reactive antigen contained in a number of strains of GBRs. When utilized in conjunction with a hyperimmune guinea pig antiserum to GBR, this monoclonal antibody can be used in an enzyme immunoassay system to detect a wide range of GBRs. Alternatively, this monoclonal antibody can be combined with sera obtained from GBR-infected animals to devise assays which are largely specific for the homologous strain of GBR. Reactivity was not noted in either system with strains of group A or group C rotaviruses or with other members of the family Reoviridae. These results indicate that GBRs contain both group-reactive and species-specific antigens which are distinct from those found in group A rotaviruses. The availability of well-defined immunoreagents will facilitate detailed studies of GBR infections in humans and animals.
No takes yet. Share an insight, caveat, or question.
Yolken et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: